Literature DB >> 12016148

Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma.

Hélène Simonnet1, Nathalie Alazard, Kathy Pfeiffer, Catherine Gallou, Christophe Béroud, Jocelyne Demont, Raymonde Bouvier, Hermann Schägger, Catherine Godinot.   

Abstract

A mechanism decreasing oxidative metabolism during normal cell division and growth is expected to direct substrates toward biosyntheses rather than toward complete oxidation to CO(2). Hence, any event decreasing oxidative phosphorylations (OXPHOS) could provide a proliferating advantage to a transformed or tumor cell in an oxidative tissue. To test this hypothesis, we studied mitochondrial enzymes, DNA and OXPHOS protein content in three types of renal tumors from 25 patients. Renal cell carcinomas (RCCs) of clear cell type (CCRCCs) originate from the proximal tubule and are most aggressive. Chromophilic RCCs, from similar proximal origin, are less aggressive. The benign renal oncocytomas originate from collecting duct cells. Mitochondrial enzyme and DNA contents in all tumor types or grades differed significantly from normal tissue. Mitochondrial impairment increased from the less aggressive to the most aggressive RCCs, and correlated with a considerably decreased content of OXPHOS complexes (complexes II, III, and IV of the respiratory chain, and ATPase/ATP synthase) rather than to the mitochondrial content (citrate synthase and mitochondrial (mt)DNA). In benign oncocytoma, some mitochondrial parameters (mtDNA, citrate synthase, and complex IV) were increased 4- to 7-fold, and some were slightly increased by a factor of 2 (complex V) or close to normal (complexes II and III). A low content of complex V protein was found in all CCRCC and chromophilic tumors studied. However F(1)-ATPase activity was not consistently decreased and its impairment was associated with increased aggressiveness in CCRCCs. Immunodetection of free F(1)-sector of complex V demonstrated a disturbed assembly/stability of complex V in several CCRCC and chromophilic tumors. All results are in agreement with the hypothesis that a decreased OXPHOS capacity favors faster growth or increased invasiveness.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016148     DOI: 10.1093/carcin/23.5.759

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  114 in total

Review 1.  Genetic insights into OXPHOS defect and its role in cancer.

Authors:  Dhyan Chandra; Keshav K Singh
Journal:  Biochim Biophys Acta       Date:  2010-11-11

Review 2.  Regulation of mitochondrial DNA content and cancer.

Authors:  Masahiro Higuchi
Journal:  Mitochondrion       Date:  2006-12-05       Impact factor: 4.160

3.  Renal oncocytoma on 1-11C acetate positron emission tomography: Case report and literature review.

Authors:  Jabi Shriki; Venkatesh Murthy; Jeffrey Brown
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 4.  Direct tissue analysis by matrix-assisted laser desorption ionization mass spectrometry: application to kidney biology.

Authors:  Kristen D Herring; Stacey R Oppenheimer; Richard M Caprioli
Journal:  Semin Nephrol       Date:  2007-11       Impact factor: 5.299

5.  PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations.

Authors:  Sarika Srivastava; John N Barrett; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2007-03-06       Impact factor: 6.150

Review 6.  Mitochondria and cancer.

Authors:  Valdemar Máximo; Jorge Lima; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2009-04-03       Impact factor: 4.064

7.  Investigation of the association between mitochondrial DNA and p53 gene mutations in transitional cell carcinoma of the bladder.

Authors:  Tuba Avcilar; Deniz Kirac; Deniz Ergec; Gulsah Koc; Korkut Ulucan; Zehra Kaya; Elif Cigdem Kaspar; Levent Turkeri; Ahmet Ilter Guney
Journal:  Oncol Lett       Date:  2016-08-11       Impact factor: 2.967

8.  A novel role for mitochondria in regulating epigenetic modification in the nucleus.

Authors:  Dominic J Smiraglia; Mariola Kulawiec; Gaia L Bistulfi; Sampa Ghoshal Gupta; Keshav K Singh
Journal:  Cancer Biol Ther       Date:  2008-08-01       Impact factor: 4.742

9.  Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma.

Authors:  Jinliang Xing; Meng Chen; Christopher G Wood; Jie Lin; Margaret R Spitz; Jianzhong Ma; Christopher I Amos; Peter G Shields; Neal L Benowitz; Jian Gu; Mariza de Andrade; Gary E Swan; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2008-07-29       Impact factor: 13.506

10.  Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia.

Authors:  Katarína Smolková; Nadège Bellance; Francesca Scandurra; Elisabeth Génot; Erich Gnaiger; Lydie Plecitá-Hlavatá; Petr Jezek; Rodrigue Rossignol
Journal:  J Bioenerg Biomembr       Date:  2010-01-19       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.